Stockscreener 앱 받기
9.71
1.12%
-0.13
전일 마감가:
$9.84
열려 있는:
$9.8
하루 거래량:
1.03M
Relative Volume:
0.49
시가총액:
$1.18B
수익:
$177.28M
순이익/손실:
$-195.24M
주가수익비율:
-7.2463
EPS:
-1.34
순현금흐름:
$-114.54M
1주 성능:
+25.23%
1개월 성능:
+30.25%
6개월 성능:
+74.37%
1년 성능:
+223.26%
1일 변동 폭
$9.465
$10.05
1주일 범위
$7.16
$10.28
52주 변동 폭
$2.99
$10.28
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
9.71 | 1.18B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
501.10 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.00 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
654.68 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.40 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
252.09 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Adaptive Biotechnologies (ADPT) Price Target Increased by Morgan Stanley | ADPT Stock News - GuruFocus
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Stock Position Lifted by Wells Fargo & Company MN - Defense World
Adaptive Biotechnologies Soars 120% In 9 MonthsCan The Momentum Continue? - RTTNews
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 12-Month High Following Earnings Beat - Defense World
Decoding Adaptive Biotechnologies Corp (ADPT): A Strategic SWOT Insight - GuruFocus
Adaptive Biotechnologies stock soars on Q1 earnings beat - Investing.com
Adaptive Biotechnologies Corp (ADPT) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results - Benzinga
Adaptive Biotechnologies Lifts Forecasts And Sees Share Price Jump - Finimize
Adaptive Biotechnologies (ADPT): Goldman Sachs Raises Price Target | ADPT Stock News - GuruFocus
Adaptive Biotechnologies rises after quarterly sales beat - TradingView
Adaptive Biotechnologies (ADPT) Soars 34% on Strong Q1 Earnings - RagingBull
Adaptive Biotechnologies: Q1 Earnings Snapshot - marketscreener.com
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highl - GuruFocus
Adaptive Biotechnologies Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Adaptive Biotechnologies (ADPT) Reports Strong Q1 2025 Earnings with Raised Guidance - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings: EPS of -$ - GuruFocus
Adaptive Biotechnologies Q1 2025 slides: MRD revenue jumps 34%, expenses decline - Investing.com Canada
Adaptive Biotechnologies Q1 2025 slides: MRD revenue jumps 34%, expenses decline By Investing.com - Investing.com South Africa
Earnings call transcript: Adaptive Biotechnologies beats Q1 2025 EPS forecast - Investing.com
Adaptive Biotechnologies earnings beat by $0.09, revenue topped estimates - Investing.com
Adaptive Biotechnologies (ADPT) Surpasses Q1 Revenue Expectations | ADPT Stock News - GuruFocus
Adaptive Biotechnologies Corp SEC 10-Q Report - TradingView
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results - TradingView
Earnings Flash (ADPT) Adaptive Biotechnologies Reports Q1 Revenue $52.4M, vs. FactSet Est of $42.7M - marketscreener.com
Taking the lead: Adaptive Biotechnologies Corp (ADPT) - Sete News
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Stock Sentiment: What’s Wall Street Saying? - Stocksregister
XTX Topco Ltd Purchases New Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - The AM Reporter
What technical indicators reveal about ADPT stock - uspostnews.com
Renaissance Technologies LLC Increases Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - American Banking and Market News
Renaissance Technologies LLC Buys 60,385 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
XTX Topco Ltd Buys Shares of 29,585 Adaptive Biotechnologies Co. (NASDAQ:ADPT) - American Banking and Market News
Legal & General Group Plc Buys 97,798 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Stock Performance Spotlight: Adaptive Biotechnologies Corp (ADPT) Ends the Day at 7.90, Up by 0.13 - DWinneX
Trading Day Review: Adaptive Biotechnologies Corp (ADPT) Loses Momentum, Closing at 7.66 - DWinneX
Adaptive Biotechnologies Corp [ADPT] Shares Rise 6.91 % on Thursday - knoxdaily.com
Adaptive Biotechnologies Corp (NASDAQ:ADPT) Could Really Rise To 18 In 12 Months, According To Analysts. - Marketing Sentinel
Adaptive Biotechnologies Corp: Weathering Stock Market Storms with 1.17B Market Cap - investchronicle.com
Cathie Wood’s ARK Sells Adaptive Biotech, Buys Beam Therapeutics Stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK Sells Adaptive Biotech, Buys Beam Therapeutics Stock - Investing.com
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Acquired by Russell Investments Group Ltd. - Defense World
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export CurbsAdvanced Micro Devices (NASDAQ:AMD), Adaptive Biotechnologies (NASDAQ:ADPT) - Benzinga
LPL Financial LLC Sells 8,470 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Insider ROBINS HARLAN S sells 1,698 of Adaptive Biotechnologies Corp [ADPT] Stock - knoxdaily.com
JPMorgan Chase & Co. Lowers Stock Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Alliancebernstein L.P. Sells 1,890 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Federated Hermes Inc. Reduces Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Franklin Resources Inc. Invests $443,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Vanguard Group Inc. Has $64.24 Million Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
0.32%
자본화:
|
볼륨(24시간):